Sign in
Stories
Visionary Growth in Eye Health
Share
AI Healthcare Innovation Awarded Again
Advancements and Challenges in Ophthalmo...
Advancements in Medical Imaging
Irlen Syndrome Conference Showcases Solu...
RetinAI Discovery® Revolutionizes Ophtha...
Overview
API
The retinal vein occlusion market is poised for substantial growth, with a projected increase from $15.43 billion in 2024 to $23.08 billion by 2028, driven by aging demographics and medical advancements. Key players like Pfizer, Roche, and Merck are spearheading innovative treatments. North America dominates the market, while Asia-Pacific shows the highest growth potential.
Ask a question
How could the dominance of North America impact global healthcare dynamics and access to innovative treatments?
How might advancements in diagnostic imaging further revolutionize retinal vein occlusion treatments?
What strategies can emerging markets adopt to capitalize on the projected growth in the retinal vein occlusion sector?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage